| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 24 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.58B | - | |
| 10% | 33.65M | $1.06B | - | |
| Pres | 18.68M | $589.84M | - | |
| CEO | 16.74M | $528.53M | - | |
| Dir | 15.35M | $484.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Gold Daniel Allen73 | Director | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | +33.2% | - | |
| Nov 17, 2025 | Ramaswamy Vivek | 10% Owner | Sell | 1,854,603 | $20.46 | $37,939,111.83 | -1.8% | +31.8% | - | |
| Nov 7, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $20.22 | $4,044,000.00 | -11.7% | +2.5% | - | |
| Oct 17, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 851,383 | $16.99 | $14,467,502.37 | -15.9% | +35.0% | - | |
| Oct 13, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 125,667 | $16.29 | $2,047,335.75 | -4.0% | +36.7% | - | |
| Oct 8, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 665,159 | $16.21 | $10,781,813.19 | -12.8% | +34.8% | - | |
| Sep 23, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 1,711,000 | $14.92 | $25,524,777.28 | -18.0% | +53.9% | - | |
| Sep 18, 2025 | Gline Matthew | CEO | Buy | 3,315 | $15.07 | $49,957.05 | - | +50.4% | - | |
| Sep 5, 2025 | Ramaswamy Vivek | 10% Owner | Sell | 1,775,749 | $12.65 | $22,456,209.72 | -1.6% | +63.9% | - | |
| Aug 20, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 100,000 | $11.72 | $1,172,000.00 | -5.7% | +75.1% | - |